Clinical Trial Update: A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAP [Phase 1, Phase 2]

View source ↗

Summary

Update on safety and efficacy results from a phase 1/2 study of the malaria vaccines R21 with ChAd63/MVA ME-TRAP; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• ChAd63-MVA ME-TRAP (ChAd63-MVA ME-TRAP viral vectored malaria vaccine)
• R21

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED